How This Works Tirzepatide is a dual GLP-1/GIP receptor agonist : it activates both the GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) incretin receptors, which together regulate appetite, glucose-dependent insulin release and glucagon [1] [5]
Bajramagic S, Sever M, Rasic F, Staresinic M, Skrtic A, Beketic Oreskovic L, et al
Key Strengths: Extensive BPC-157 and TB-500 offerings including individual vials, combination blends, and custom concentrations for high-volume clinics
Resources like the SeekPeptides peptide calculator can handle these calculations automatically if you prefer not to do the math yourself
Immune rebalancing: Elsevier